Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
about
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesPharmaceutical particle engineering via spray drying.Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.Nanodelivery in airway diseases: challenges and therapeutic applications.Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.Polymeric Materials for Gene Delivery and DNA VaccinationDevelopment and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes.Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.Programmed Application of Transforming Growth Factor β3 and Rac1 Inhibitor NSC23766 Committed Hyaline Cartilage Differentiation of Adipose-Derived Stem Cells for Osteochondral Defect Repair.Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivoIsoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Nanoparticles as carriers for nasal vaccine delivery.The role of adjuvants in the development of mucosal vaccines.Strategies for DNA vaccine delivery.Noninvasive delivery technologies: respiratory delivery of vaccines.Leptospirosis vaccines.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.Strategies for intranasal delivery of vaccinesThe performance of nanocarriers for transmucosal drug delivery.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationColloidal microgels in drug delivery applicationsImplication of nanoparticles/microparticles in mucosal vaccine delivery.Intranasal vaccines for protection against respiratory and systemic bacterial infections.Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.Needle-free vaccine delivery.Design of nanoparticle-based dry powder pulmonary vaccines.Chitosan-based systems for the delivery of vaccine antigens.Mucosal Vaccine Development Based on Liposome Technology.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Liposomes as delivery systems for nasal vaccination: strategies and outcomes.Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.Delivery of antigens used for vaccination: recent advances and challenges.Nanocarriers targeting dendritic cells for pulmonary vaccine delivery.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.
P2860
Q28294355-B7D0EBB5-342D-426E-8795-7157FEAF1CB4Q30496354-5155BEB6-A4A4-4489-823F-B2021C68F102Q30844270-5B0F2545-5102-4F9F-B6D0-1151015AEC56Q33353872-135D9CC4-B6CF-4857-897D-7110928A774DQ33483926-86995C7B-ADE7-4AB1-8C01-0EECF8AFC101Q33563553-9E130D13-8A4E-4F89-999F-6FCDDE5BC88DQ33565296-5630DC96-9997-42B9-8C93-9FE6B27E382BQ33782651-66E17295-50E0-446F-B5CB-1EC364D0BB38Q33954601-9DC934E3-9FCC-48E5-82D5-24AEFB3AAC87Q34273099-6DC25458-7FBF-4D34-92D1-96E44292119BQ34484116-06DA1004-0B09-42E3-BB06-A47756AD6075Q34818656-6094BE76-19F4-4097-A641-54FEC36C1102Q34910919-95A3BC8B-616C-45CD-821B-7EE139C682F1Q35112676-51F3C693-C645-49F8-88C2-51A5B35742F9Q36124952-8BCF698B-DB7C-4354-9A1F-C93980D6EE56Q36194084-543A6C69-AE03-4DCB-8304-C3D8F779203BQ36316818-0D5C418C-71EE-44B1-A814-6B37A74C57BDQ36349694-84F8DC68-B6F8-4701-A202-310C9CBF66D2Q36440093-56CD599C-87FA-4F12-99B9-252EAF668B54Q36498186-CD86B8D7-FAC5-47B0-874C-8A9A8E521CBFQ36502198-69746FC7-48F4-4C21-B6BE-7BE6DBB4FD07Q36514771-F7499A0D-E028-4A5D-BEC8-E248789D8470Q36527739-619F0899-937E-4920-B788-DA0EB43C321EQ36598433-D389D459-BD54-4FDB-BC49-9C53F9A2C203Q36683664-CF9BF3E5-E3C4-455D-8E17-ABD1A94E4CFEQ36837152-606A3A5D-FEA5-4886-A024-E3ABF8FD9BD0Q36837156-9E05A363-632C-4A28-AFB0-8B96E0C51988Q36941463-9542B5E1-E328-4869-826C-35CEAAA2284AQ36945838-4CD2C1C7-F344-4804-ADF8-F70B9ACA4BCAQ36985908-1FC118F4-B4A5-4DBA-B6A6-555206AA588FQ37524050-9F026FDE-EA64-4484-A230-8E38417DEA07Q37581129-99FE25A1-E18E-4B93-81A9-880863669EDDQ37671847-E917B702-3F61-419D-8771-E2E764D1A868Q37748791-6866AB35-95F9-409F-9A04-E15BD1BB7A72Q37818335-3A4107C8-CC3B-49F4-8F25-49E98AE2A2CAQ38028969-2F5A215D-0CA1-4CEE-BD85-319C76C98111Q38051096-58C30C46-4B78-489B-A169-849F154F9411Q38066148-E75C990A-AAC6-4CF1-8BD9-E17ACC4117F0Q38261366-8E320862-CC6D-4BEC-AE04-46746864BB2FQ38400992-A8CB68D0-0B0C-4463-817B-D6EDA9003953
P2860
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@ast
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@en
type
label
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@ast
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@en
prefLabel
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@ast
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@en
P2093
P1476
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
@en
P2093
H Oya Alpar
S Somavarapu
V W Bramwell
P304
P356
10.1016/J.ADDR.2004.09.004
P407
P577
2005-01-01T00:00:00Z